Admission Date:  [**2129-12-5**]              Discharge Date:   [**2129-12-28**]  Date of Birth:  [**2062-5-24**]             Sex:   F  Service: SURGERY  Allergies: Nitrofurantoin / Yellow Dye / Iron / Calcium  Attending:[**First Name3 (LF) 2836**] Chief Complaint: Increased abdominal pain   Major Surgical or Invasive Procedure: ERCP  History of Present Illness: 67 yo F with h/o PUD which was c/b gastric outlet obstruction s/p vagotomy, antrectomy and bilroth II repair [**4-22**] c/b jejunal stump leak and recurrent liver abscesses s/p drainage and fistula creation, polymicrobial BSI s/p treatment course of daptomycin, meropenem, fluconazole (finished course of IV abx on [**2129-11-17**]) presenting with worsening abdominal pain.
Patient has had an extensive medical course since surgery in [**4-22**] including multiple hospitalizations and rehab stays and was on IV abx until [**2129-11-17**].
Patient doesn't remember the fall, but she had just taken several pain medications (incl dilaudid, which she takes every 4 hours 4 mg without fail) and per her daughter and husband she often gets confused after taking her medications.
She received dilaudid 1 mg IV x 2, zofran as well as IV ativan.
Surgery recommended no intervention now, admit to medicine for IV abx for PNA with surgery following.
Pt was given dose of vanco/zosyn for HCAP.
Currently, patient complains of [**4-21**] pain, much imprved from when she came in, howver she is not oriented to place or year having just received IV ativan and dilaudid.
Per Opt ID note: Subsequent course after initial surgery was complicated by polymicrobial BSI (Enterobacter cloacae, VRE, MRSA, Clostridium) and hepatic abscess requiring drainage on [**6-1**] (Enterobacter, Enterococcus) s/p drain removal and prolonged course of antibiotic therapy (daptomycin, ertapenem) ending [**7-6**].
Treatment with daptomycin and meropenem was re-initiated.
Micafungin was added to her antibiotic regimen.
In the setting of a persistent leukocytosis, she was found to have a new liver abscess on [**7-30**] and underwent CT guided drainage with fluid growing VRE, MRSA and yeast.
however due to abdominal cramping which may have been in part related to tigecycline, her regimen was changed to daptomycin, ertapenem, and fluconazole on [**2129-8-11**].
On [**8-17**] she was readmitted to the hospital for elevation of LFTs and increasing abdominal pain.
Patient was maintained on Daptomycin and Fluconazole however Ertapenem was changed to Meropenem on [**8-18**].
Decision was made to maintain the patient on Meropenem on discharge instead of ertapenem for coverage of Enterbacter which grew previously as she seemed to have improvement in her abdominal pain, transaminitis, and remained afebrile with Meropenem.
Antibiotic course: [**Date range (1) 90350**] Daptomycin, Ertapenem [**Date range (1) 3047**] Daptomycin [**Date range (1) 90351**] Linezolid [**Date range (1) 90352**] Meropenem [**Date range (1) 29023**] Tigecycline (switched due to abd cramping) [**Date range (1) 90353**] Micafungin [**8-11**] abx changed to Daptomycin, Ertapenem, and Fluconazole on discharge [**8-18**] Daptomycin and Fluconazole continued from previous discharge and Ertapenem changed to Meropenem .
An was started on Bactrim DS 1 tab po BID and continue Fluconazole 400mg po daily.
Past Medical History: chronic back pain sciatica HTN PUD adrenal adenoma uterine CA s/p hysterectomy depression anemia of chronic disease recurrent hepatic abscess Polymicrobial bacteremia - Enterobacter cloacae, VRE, MRSA, Clostridium - s/p several month course of abx, most recently daptomycin and meropenem (see ID OPAT note for details) Abdominal fluid collections growing [**Female First Name (un) 564**] albicans and [**Female First Name (un) 29361**], VRE Right hepatic vein thrombosis, on warfarin .
PSH: EUS, pyloric ulcer bx, perigastric LNB ([**2129-4-25**]) EGD with duodenal stricture dilation ([**2129-4-25**]) Vagotomy and antrectomy with B2 reconstruction ([**2129-5-5**]) Re-exploration,lateral duo tube and feeding J-tube ([**2129-5-7**]) CT-guided catheter drainage of liver abscess ([**2129-6-1**]) perforated cyst/appendix s/p SBR, appendectomy cystectomy as a teenager s/p hysterectomy for uterine cancer @age 29   Social History: Lives at home with husband, was in long term rehab ([**Name (NI) 5682**] ECF) since her discharge in [**9-22**].
Family History: Father with peptic ulcer disease  Physical Exam: On Admission: VS - 97.0 119/66 89 20 95% 2L GENERAL - thin and frail appearing F in NAD, comfortable, appears sleepy HEENT - NC/AT, PERRLA, EOMI, sclerae anicteric, MMM, OP clear NECK - supple, no thyromegaly, no JVD, no carotid bruits LUNGS - + crackles about 1/3 up from base of L lung field, no wheezes, good air movement, resp unlabored, no accessory muscle use HEART - PMI non-displaced, RRR, no MRG, nl S1-S2 ABDOMEN - NABS, soft, diffusely TTP more prominantly in RLQ, no rebound/guarding, fistula output on R side with green turbid fluid, no masses or HSM EXTREMITIES - WWP, no c/c/e, 2+ peripheral pulses (radials, DPs)  SKIN - no rashes or lesions LYMPH - no cervical, axillary, or inguinal LAD NEURO - awake, alert, oriented ot self, month, not to year or place (knows she is at hospital but thinks [**Hospital1 **]), CNs II-XII grossly intact, muscle strength 5/5 throughout  On Discharge: VS: GEN: CV: PULM: ABD: EXTR: NEURO:   Pertinent Results: [**2129-12-21**] 10:15AM BLOOD WBC-20.1* RBC-3.14* Hgb-8.3* Hct-26.5* MCV-84 MCH-26.6* MCHC-31.5 RDW-19.7* Plt Ct-612* [**2129-12-21**] 06:10AM BLOOD Glucose-83 UreaN-21* Creat-0.5 Na-135 K-4.6 Cl-104 HCO3-21* AnGap-15 [**2129-12-21**] 06:10AM BLOOD Calcium-8.3* Phos-4.4 Mg-2.1 [**2129-12-21**] 06:10AM BLOOD PT-16.3* PTT-26.6 INR(PT)-1.4* [**2129-12-22**] 05:17AM BLOOD WBC-19.2* RBC-2.83* Hgb-7.5* Hct-24.0* MCV-85 MCH-26.6* MCHC-31.3 RDW-20.6* Plt Ct-457* [**2129-12-21**] 06:10AM BLOOD Glucose-83 UreaN-21* Creat-0.5 Na-135 K-4.6 Cl-104 HCO3-21* AnGap-15 [**2129-12-21**] 06:10AM BLOOD Calcium-8.3* Phos-4.4 Mg-2.1  [**2129-12-5**] 4:45 am URINE      Source: Catheter.
Interval decrease in mid abdominal collections in the region of prior surgery at the duodenal stump with no new fluid collections identified; however, a few small bubbles of gas remain with the shrunken residual collection.
Brief Hospital Course: 67 yo F with h/o PUD which was c/b gastric outlet obstruction s/p vagotomy, antrectomy and Billroth II repair [**4-22**] c/b jejunal stump leak and recurrent liver abscesses s/p drainage and fistula creation, polymicrobial BSI s/p treatment course of daptomycin, meropenem, fluconazole (finished course of IV abx on [**2129-11-17**]) presenting with acute onset sharp abdominal pain, LLL infiltrate on CXR and CT and unchanged abdominal collections .
She was placed on linezolid and meropenem.
She underwent ERCP on 10/27th and was hold off Coumadin prior to her going over for ERCP.
After she returned, heparin gtt was started with bridge to warfarin.
She became supratherapeutic and her Coumadin was held until her INR normalized.
Imaging does not support intra-abdominal process, but given extensive history, still a concern.
Knowing her history with multiple drug resistant organisms in blood stream infections, including VRE, Enterobacter resistant to pip/tazo (from [**2129-5-31**]), she was changed to IV linezolid/meropenem.
The patient underwent empirical treatment with IV Linezolid, Meropenem and Fluconazole, after completion of the course, she was restarted on her home antibiotic coverage with Bactrim DS and PO Fluconazole.
The patient was made NPO with NGT, IVF and nutritional service was called for TPN recommendations.
PICC line was placed and TPN was started on [**2129-12-17**].
Diet was advanced to regular on [**12-21**], and TPN was discontinued.
Fentanyl patch was added to achieve better pain control per Chronic Pain Service.
The patient was discharged home with instruction to taper down her Fentanyl patch within 3 weeks.
Medications on Admission: -CARISOPRODOL 350 mg Tablet by mouth three times daily -CITALOPRAM 10 mg Tablet by mouth daily -DRONABINOL 2.5 mg Capsule by mouth twice daily -HYDROMORPHONE 2 mg Tablet 2 Tablet(s) by mouth every 4 hours -HYOSCYAMINE SULFATE 0.375 mg Tablet daily -MEGESTROL [MEGACE ES] 40mg [**Hospital1 **] -METOPROLOL TARTRATE 50 mg Tablet - 1 Tablet(s) by mouth twice a day -MIRTAZAPINE  15 mg Tablet by mouth at bedtime -PANTOPRAZOLE 40 mg Tablet by mouth daily -SULFAMETHOXAZOLE-TRIMETHOPRIM - 800 mg-160 mg Tablet - [**Hospital1 **] -WARFARIN 0.5 daily -Flagyl 200mg 2tabs  daily -Fentanyl 25mcg/hr TP Q72H -DOCUSATE SODIUM 100 mg Capsule - 1 Capsule(s) by mouth twice daily -POLYETHYLENE GLYCOL 3350 [MIRALAX] -17 g daily   Discharge Medications: 1. fluconazole 200 mg Tablet Sig: Two (2) Tablet PO Q24H (every 24 hours).
Disp:*60 Tablet(s)* Refills:*0* 2. carisoprodol 350 mg Tablet Sig: One (1) Tablet PO TID (3 times a day).
3. hydromorphone 2 mg Tablet Sig: 1-2 Tablets PO every four (4) hours as needed for pain.
Disp:*60 Tablet(s)* Refills:*0* 4. hyoscyamine sulfate 0.375 mg Capsule,Extended Release 12 hr Sig: One (1) Capsule,Extended Release 12 hr PO BID (2 times a day).
Disp:*60 Capsule,Extended Release 12 hr(s)* Refills:*0* 5. metoprolol tartrate 50 mg Tablet Sig: One (1) Tablet PO BID (2 times a day).
)(s)* Refills:*2* 7. docusate sodium 100 mg Capsule Sig: One (1) Capsule PO BID (2 times a day).
Disp:*60 Capsule(s)* Refills:*2* 8. senna 8.6 mg Tablet Sig: One (1) Tablet PO BID (2 times a day) as needed for constipation.
9. megestrol 400 mg/10 mL (40 mg/mL) Suspension Sig: One (1)  PO BID (2 times a day).
Disp:*60 * Refills:*2* 10. acetaminophen 500 mg Tablet Sig: Two (2) Tablet PO Q6H (every 6 hours) as needed for pain.
11. citalopram 10 mg Tablet Sig: One (1) Tablet PO once a day.
Bactrim DS 800-160 mg Tablet Sig: One (1) Tablet PO twice a day: Start on [**2129-12-20**].
Disp:*60 Tablet(s)* Refills:*0* 13. lisinopril 20 mg Tablet Sig: One (1) Tablet PO DAILY (Daily).
Disp:*30 Tablet(s)* Refills:*0* 14. warfarin 1 mg Tablet Sig: One (1) Tablet PO once a day: PLease continue to check INR.
Disp:*30 Tablet(s)* Refills:*2* 15. fentanyl 25 mcg/hr Patch 72 hr Sig: One (1) patch Transdermal every seventy-two (72) hours for 3 doses.
Disp:*3 patches* Refills:*0* 16. fentanyl 50 mcg/hr Patch 72 hr Sig: One (1) patch Transdermal every seventy-two (72) hours for 3 doses: Please use 50 mcg/hr patch x 3 times, then continue with 25 mcg/hr patch x 3, then stop Fentanyl patch.
Also, please take any new medications as prescribed.
Avoid driving or operating heavy machinery while taking pain medications.
Right abdominal drain (ostomy) site: Empty pouch when it is [**2-14**] full and document output from drain site.
Change ostomy appliance twice a week.
Monitor erythema and induration peri drain site.
Coumadin (Warfarin): What is this medicine used for?
These include wheezing; chest tightness; fever; itching; bad cough; blue skin color; fits; or swelling of face, lips, tongue, or throat, severe dizziness or passing out, falls or accidents, especially if you hit your head.
Coumadin (Warfarin) and diet: Certain foods and beverages can impair the effect of warfarin.
Until recently, doctors advised [**Name5 (PTitle) **] taking warfarin to avoid foods high in vitamin K. This is because large amounts of vitamin K can counteract the benefits of warfarin.
These foods contain vitamin K: Fruits and vegetables, such as: Kiwi, Blueberries, Broccoli, Cabbage, [**Location (un) 2831**] sprouts, Green onions, Asparagus, Cauliflower, Peas, Lettuce, Spinach, Turnip, collard, and mustard greens, Parsley, Kale, Endive.
Be careful on special occasions or holidays, and drink only what you usually would on any regular day of the week.
It is very important to talk with your doctor about all of the other medicines that you are taking, including over-the-counter medicines, antibiotics, vitamins, or herbal products.
The [**Month/Day (3) 269**] will check you blood for Coumadin level.
They will send results to your PCP (Dr. [**Name (NI) 70277**]) and he will continue to adjust your Coumadin intake.
Please continue to taper down your Fentanyl patch as prescribed.
Please follow up with you PCP ( Dr. [**Name (NI) 70277**]) to continue monitor you INR level in [**2-13**] weeks after discharge.
